Author： Loo Angela S Muhsin Saif A Walsh Thomas J
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.12, Iss.6, 2013-11, pp. : 881-895
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Safety of aerosolized amphotericin B
By Knechtel Stephanie A Klepser Michael E
Expert Opinion on Drug Safety, Vol. 6, Iss. 5, 2007-09 ,pp. :
Access to resources
Recommend
Amphotericin B liposomal: Pseudohyperphosphataemia: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. :
Amphotericin B liposomal: Liver injury: case report
Reactions Weekly, Vol. 1, Iss. 1237, 2009-01 ,pp. :
Micafungin vs liposomal amphotericin B in candidiasis
Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. :
Liposomal amphotericin B as a treatment for human leishmaniasis
Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. :